icd10coded.com
  • ICD-10 CM
    • ICD-10 CM Diagnosis Codes
    • Convert ICD-9 to ICD-10
    • Index of Diseases and Injuries
    • Index of External Cause of Injuries
    • Table of Neoplasms
    • Table of Drugs & Chemicals
    • POA Reporting Guidelines
    • POA Codes
    • Diagnosis Related Groups - MS-DRG
  • ICD-10 PCS
    • ICD-10 PCS Procedure Codes
    • ICD-10 PCS Index
    • ICD-10 PCS Definitions
    • Device Aggregation Table
    • Diagnosis Related Groups - MS-DRG
  • Coding Rules
    • Perinatal/Newborn diagnoses
    • Pediatric diagnoses
    • Maternity diagnoses
    • Adult diagnoses
    • Diagnoses for females only
    • Diagnoses for males only
    • Procedures for females only
    • Procedures for males only
    • Unacceptable principal diagnosis
    • Questionable admission codes
    • Manifestation code as principal diagnosis
  • Clinical Concept
    • Allergy
    • Cardiology
    • Endocrinology
    • Family Practice
    • Internal Medicine
    • OB/GYN
    • Orthopedics
    • Pediatrics
    • Physical Therapy
  • Search
  1. Home
  2. ICD-10 CM
  3. C7A.093
  4. Feedback

ICD-10 Code C7A.093
Malignant carcinoid tumor of the kidney

C7A.093 is the ICD-10-CM code designated for a malignant neuroendocrine tumor of the thyroid gland. This clinical classification encompasses rare cancerous growths originating from neuroendocrine cells within the thyroid, such as C-cells or parafollicular cells, which are responsible for producing calcitonin. Patients with this condition often present with a palpable thyroid nodule or neck mass, dysphagia, hoarseness from local nerve compression, or systemic paraneoplastic symptoms such as flushing and chronic diarrhea resulting from hormone hypersecretion. Diagnostic confirmation involves neck ultrasonography, fine-needle aspiration biopsy, serum calcitonin and carcinoembryonic antigen marker evaluation, and specialized imaging. Related diseases and conditions associated with this code include medullary thyroid carcinoma, primary carcinoid tumor of the thyroid gland, high-grade thyroid neuroendocrine carcinoma, and hereditary endocrine tumor disorders such as multiple endocrine neoplasia type 2.


C7A.093 is a valid billable ICD-10 diagnosis code for Malignant carcinoid tumor of the kidney. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.


See also, ICD-10 Table of Neoplasms.

MS-DRG - Medicare Severity-Diagnosis Related Group
  • MDC 11 Diseases & Disorders of the Kidney & Urinary Tract
    Kidney and Ureter Procedures
    • DRG 656 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC
    • DRG 657 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC
    • DRG 658 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC
  • MDC 11 Diseases & Disorders of the Kidney & Urinary Tract
    Kidney and Urinary Tract Neoplasms
    • DRG 686 - KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC
    • DRG 687 - KIDNEY AND URINARY TRACT NEOPLASMS WITH CC
    • DRG 688 - KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC

Coding structure:

ICD-10 code C7A.093 is based on the following Tabular structure:

Chapter 2: Neoplasms
  • Section C7A: Malignant neuroendocrine tumors
    • Category C7A: Malignant neuroendocrine tumors

↑ Parent code:
C7A.09 for Malignant carcinoid tumors of other sites

C7A.093_
Category
 
Etiology, Anatomic Site,
Severity, Other Vital Details
Extension

Should you use C7A.093 or C7A093 (with or without decimal point) when submitting claims?

DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.

Section C7A — Malignant neuroendocrine tumors
  1. C7A Malignant neuroendocrine tumors

    Use additional code to identify any associated endocrine syndrome, such as:
    carcinoid syndrome (E34.00)

    Excludes2

    • malignant pancreatic islet cell tumors (C25.4)
    • Merkel cell carcinoma (C4A.-)
    1. C7A.0 Malignant carcinoid tumors

      1. C7A.00 Malignant carcinoid tumor of unspecified site

      2. C7A.01 Malignant carcinoid tumors of the small intestine

        • C7A.010 Malignant carcinoid tumor of the duodenum
        • C7A.011 Malignant carcinoid tumor of the jejunum
        • C7A.012 Malignant carcinoid tumor of the ileum
        • C7A.019 Malignant carcinoid tumor of the small intestine, unspecified portion
      3. C7A.02 Malignant carcinoid tumors of the appendix, large intestine, and rectum

        • C7A.020 Malignant carcinoid tumor of the appendix
        • C7A.021 Malignant carcinoid tumor of the cecum
        • C7A.022 Malignant carcinoid tumor of the ascending colon
        • C7A.023 Malignant carcinoid tumor of the transverse colon
        • C7A.024 Malignant carcinoid tumor of the descending colon
        • C7A.025 Malignant carcinoid tumor of the sigmoid colon
        • C7A.026 Malignant carcinoid tumor of the rectum
        • C7A.029 Malignant carcinoid tumor of the large intestine, unspecified portion

          Inclusion term(s):

          • Malignant carcinoid tumor of the colon NOS
      4. C7A.09 Malignant carcinoid tumors of other sites

        • C7A.090 Malignant carcinoid tumor of the bronchus and lung
        • C7A.091 Malignant carcinoid tumor of the thymus
        • C7A.092 Malignant carcinoid tumor of the stomach
        • C7A.093 Malignant carcinoid tumor of the kidney
        • C7A.094 Malignant carcinoid tumor of the foregut, unspecified
        • C7A.095 Malignant carcinoid tumor of the midgut, unspecified
        • C7A.096 Malignant carcinoid tumor of the hindgut, unspecified
        • C7A.098 Malignant carcinoid tumors of other sites
    2. C7A.1 Malignant poorly differentiated neuroendocrine tumors

      Inclusion term(s):

      • Malignant poorly differentiated neuroendocrine tumor NOS
      • Malignant poorly differentiated neuroendocrine carcinoma, any site
      • High grade neuroendocrine carcinoma, any site
    3. C7A.8 Other malignant neuroendocrine tumors

Abbreviations used here:

NEC Not elsewhere classifiable
This abbreviation in the Tabular List represents “other specified”. When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code.

NOS Not otherwise specified
This abbreviation is the equivalent of unspecified.

This note further define, or give examples of, the content of the code or category.

List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.

A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

Feedback

Finding the right ICD-10 code is not always easy. Submitting the wrong code can cause delays in processing claims and payments. Please let us know if there is anything we can do better to help make your job easier. We strive to be the best ICD-10 site possible.

Share this page

Was the information found on this page useful? Share this page with a friend or colleague. They may also find it useful. We can send an email to someone you designate with this information as well.

  • ICD-10 CM
  • ICD-10 PCS
  • FAQs
  • Sitemap
  • →
  • Terms of Use
  • Privacy Policy
  • Contact Us
Follow @icd10coded

ICD-10 data provided by CMS (Centers for Medicare & Medicaid Services). All content is provided “AS IS”. The latest version of ICD-10 is updated each year on October 1.

1.261103a — Privacy Settings